Suppression of adrenal gland‐derived epinephrine enhances the corticosterone‐induced antinociceptive effect in the mouse formalin test
- 23 October 2013
- journal article
- research article
- Published by Wiley in European journal of pain
- Vol. 18 (5) , 617-628
Abstract
Background: There is both clinical and experimental evidence to support the application of corticosterone in the management of inflammation and pain. Corticosterone has been used to treat painful inflammatory diseases and can produce antinociceptive effects. Epinephrine is synthesized from norepinephrine by the enzyme phenylethanolamineN‐methyltransferase (PNMT) and works as an endogenous adrenoceptor ligand secreted peripherally by the adrenal medulla. It is currently unclear whether corticosterone's antinociceptive effect is associated with the modulation of peripheral epinephrine.Methods: We first determined whether exogenous corticosterone treatment actually produced an antinociceptive effect in a formalin‐induced pain model, and then examined whether this corticosterone‐induced antinociceptive effect was altered by suppression of adrenal‐derived epinephrine, using the following three suppression methods: (1) inhibition of thePNMTenzyme; (2) blocking peripheral epinephrine receptors; and (3) adrenalectomy.Results: Exogenous treatment with corticosterone at a high dose (50 mg/kg), but not at lower doses (5, 25 mg/kg), significantly reduced pain responses in the late phase. Moreover, injection of 2,3‐dichloro‐a‐methylbenzylamine, aPNMTenzyme inhibitor, (10 mg/kg) before corticosterone treatment caused a leftward shift in the dose‐response curve for corticosterone and injection of propranolol (5 mg/kg), but not phentolamine, also shifted the dose‐response curve to the left during the late phase. Chemical sympathectomy with 6‐hydroxydopamine had no effect on corticosterone‐induced antinociceptive effect, but injection of a low dose of corticosterone produced an antinociceptive effect in adrenalectomized animals.Conclusions: These results demonstrate that suppression of epinephrine, derived from adrenal gland, enhances the antinociceptive effect of exogenous corticosterone treatment in an inflammatory pain model.Keywords
This publication has 47 references indexed in Scilit:
- Indirect role of β2-adrenergic receptors in the mechanism of analgesic action of nonsteroidal antiinflammatory drugsCritical Care Medicine, 2010
- GLUCOCORTICOID TREATMENT-EFFECT ON ADRENAL MEDULLARY CATECHOLAMINE PRODUCTIONShock, 2010
- Roles of corticosterone in formalin-induced conditioned place aversion in ratsNeuroscience Letters, 2009
- Sound Stress–Induced Long-Term Enhancement of Mechanical Hyperalgesia in Rats Is Maintained by Sympathoadrenal CatecholaminesThe Journal of Pain, 2009
- New insights of dimethyl sulphoxide effects (DMSO) on experimental in vivo models of nociception and inflammationPharmacological Research, 2008
- Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoidsPain, 2008
- Systemic Antiinflammatory Corticosteroid Reduces Mechanical Pain Behavior, Sympathetic Sprouting, and Elevation of Proinflammatory Cytokines in a Rat Model of Neuropathic PainAnesthesiology, 2007
- Gene Expression of Phenylethanolamine N-Methyltransferase in Corticotropin-Releasing Hormone Knockout Mice During Stress ExposureCellular and Molecular Neurobiology, 2006
- Endogenous and exogenous glucocorticoid suppresses up-regulation of preprodynorphin mRNA and hyperalgesia in rats with peripheral inflammationNeuroscience Letters, 2004
- Hormonal Control of Rat Adrenal Phenylethanolamine N-Methyltransferase Enzyme Activity, the Final Critical PathwayNeuropsychopharmacology, 1995